Report overview
This report contains market size and forecasts of Intravenous(IV) Iron Drugs in global, including the following market information:
Global Intravenous(IV) Iron Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intravenous(IV) Iron Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intravenous(IV) Iron Drugs companies in 2021 (%)
The global Intravenous(IV) Iron Drugs market was valued at 1472.2 million in 2021 and is projected to reach US$ 1925.2 million by 2028, at a CAGR of 3.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ferric Carboxymaltose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intravenous(IV) Iron Drugs include Sanofi US, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous(IV) Iron Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous(IV) Iron Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravenous(IV) Iron Drugs Market Segment Percentages, by Type, 2021 (%)
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others
Global Intravenous(IV) Iron Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravenous(IV) Iron Drugs Market Segment Percentages, by Application, 2021 (%)
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Global Intravenous(IV) Iron Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravenous(IV) Iron Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous(IV) Iron Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intravenous(IV) Iron Drugs revenues share in global market, 2021 (%)
Key companies Intravenous(IV) Iron Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Intravenous(IV) Iron Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
